Primary tabs
The list of publications is indicative and may not include all publications.
Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer..
J Cancer. 11(11), 3407-3415.
(2020).
Inhaled chemotherapy adverse effects: mechanisms and protection methods..
Lung Cancer Manag. 8(4), LMT19.
(2020).
Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?.
J Cancer. 11(6), 1606-1613.
(2020).
Producing the appropriate model and drug for intratumoural ablation..
Br J Cancer. 123(3), 335-336.
(2020).
Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer..
Respir Med Case Rep. 31, 101258.
(2020).
Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination..
Expert Rev Respir Med.
(2020).
Update on current pancreatic treatments: from molecular pathways to treatment.
Journal of Cancer. 10(21), 5162 - 5172.
(2019).
EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE ®.
Journal of Cancer. 10(20), 4739 - 4746.
(2019).
Inhaled Cisplatin for NSCLC: Facts and Results..
Int J Mol Sci. 20(8),
(2019).
Genes' Interactions: A Major Contributor to the Malignant Transformation of Endometriosis..
Int J Mol Sci. 20(8),
(2019).
Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis..
Medicina (Kaunas). 55(12),
(2019).
Scar tissue to lung cancer; pathways and treatment..
J Cancer. 10(4), 810-818.
(2019).
Targeted Nanotechnology from Bench to Bedside..
Curr Cancer Drug Targets. 19(1), 3-4.
(2019).
Update on current pancreatic treatments: from molecular pathways to treatment..
J Cancer. 10(21), 5162-5172.
(2019).
EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE..
J Cancer. 10(20), 4739-4746.
(2019).
Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review..
Arch Gynecol Obstet. 300(4), 849-859.
(2019).
Aerosol Immunotherapy with or without Cisplatin for metastatic lung cancer non-small cell lung cancer disease: Study. A more efficient combination..
J Cancer. 9(11), 1973-1977.
(2018).
Beware of hemopneumothorax following core needle breast biopsy..
Respir Med Case Rep. 25, 49-51.
(2018).
Lung cancer induced from chemotherapy a 20 years old case.
Respiratory Medicine Case Reports. 24, 32 - 34.
(2018).
Conventional Versus Therapeutic Stents for Airway Malignancies: Novel Local Therapies Underway..
EBioMedicine. 33, 10-11.
(2018).
Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS)..
Respir Med Case Rep. 24, 95-97.
(2018).
Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases..
Respir Med Case Rep. 24, 5-7.
(2018).
Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: tumor mutation burden and PD-L1 ≥50..
Transl Lung Cancer Res. 7(Suppl 1), S28-S30.
(2018).
Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible..
J Cancer. 9(6), 1121-1126.
(2018).
The cost of hospital treatment of advanced stage lung cancer patients in a developing South East European country..
J Cancer. 9(17), 3038-3045.
(2018).